3697-68-5Relevant academic research and scientific papers
ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS
-
Paragraph 0736-0737, (2020/04/09)
The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.
BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF
-
Page/Page column 124; 125, (2019/02/02)
The invention provides novel compounds having the general formula (I): (I) wherein R1, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.
PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
-
Paragraph 0451; 0452, (2016/05/02)
This document discloses molecules having the following formula (“Formula One”): and processes related thereto.
TRI-HETEROCYCLIC DERIVATIVES, PREPARATION PROCESS AND USES THEREOF
-
Paragraph 0124; 0371 0372, (2014/11/13)
The present invention relates to a tri-heterocyclic derivatives, preparation process and uses thereof, specifically relates to a tri-heterocyclic derivatives of the formula (I) or a pharmaceutically acceptable salt thereof, preparation process, and further relates to a pharmaceutically acceptable composition comprising compounds of formula (I), or a pharmaceutically acceptable salt thereof, and their pharmaceutical use as inhibitors of kinase.
TRI-HETEROCYCLIC DERIVATIVES, PREPARATION PROCESS AND USES THEREOF
-
Page/Page column 43, (2013/07/05)
The present invention relates to a tri-heterocyclic derivatives, preparation process and uses thereof, specifically relates to a tri-heterocyclic derivatives of the formula (I) or a pharmaceutically acceptable salt thereof, preparation process, and further relates to a pharmaceutically acceptable composition comprising compounds of formula (I), or a pharmaceutically acceptable salt thereof, and their pharmaceutical use as inhibitors of kinase
PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
-
Paragraph 0400; 0401, (2013/05/09)
This document discloses molecules having the following formula (“Formula One”): and processes related thereto.
PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
-
Paragraph 0450-0451, (2013/11/06)
This document discloses molecules having the following formula (“Formula One”): and processes related thereto.
[1,2,4]TRIAZOLOPYRIDINES AND THEIR USE AS PHOSPODIESTERASE INHIBITORS
-
Page/Page column 15, (2013/07/05)
The present invention relates to novel [1,2,4]triazolopyridine compounds with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
NOVEL HETEROARYL-AMINO DERIVATIVES
-
Page/Page column 39, (2013/05/09)
Disclosed is a compound of formula (I), wherein R1, R2, L, Rm and Rn are as defined herein. The compound of formula (I) may be used in preventing and/or treating acyl CoA-diacylglycerol acyltransferase 1(DGAT-1) related diseases, such as obesity, coronary disease, hypertension, hyperlipidemia, arteriosclerosis, type II diabetes, stroke, hepatitis C, and the like.
Pesticidal Compositions and Processes Related Thereto
-
Page/Page column 38, (2012/05/07)
This document discloses molecules having the following formula (“Formula One”): and processes related thereto.
